FINISHED DOSAGE FORMULATIONS
Drug : DEPAKENE
Dosage Form : SYRUP; ORAL
Application Number : 18082
Country : US
Patented : No
Drug : LEXAPRO
Dosage Form : SOLUTION; ORAL
Application Number : 21365
Country : US
Patented : No
Drug : DEPAKENE
Dosage Form : CAPSULE; ORAL
Application Number : 18081
Country : US
Patented : No
Drug : CARAFATE
Dosage Form : SUSPENSION; ORAL
Application Number : 19183
Country : US
Patented : No
Drug : CYCLOSPORINE
Dosage Form : SOLUTION; ORAL
Application Number : 65054
Country : US
Patented : No
Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65044
Country : US
Patented : No
Drug : VERSACLOZ
Dosage Form : SUSPENSION; ORAL
Application Number : 203479
Country : US
Patented : Yes
Drug : ARISTOSPAN
Dosage Form : INJECTABLE; INJECTION
Application Number : 16466
Country : US
Patented : No
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Drug : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : SOLUTION; ORAL
Application Number : 40881
Country : US
Patented : No
Drug : NITROFURANTOIN
Dosage Form : SUSPENSION; ORAL
Application Number : 201355
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SORBITOL
Route : BUCCAL
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 257
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : DENTAL
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : INTRA-ARTICULAR
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 84.83
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : INTRALESIONAL
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 45
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : INTRAMUSCULAR
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 84.83
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : INTRASYNOVIAL
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 84.83
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : INTRAVENOUS
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 22.5
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : INTRAVENOUS
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 5.43
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : INTRAVENOUS
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 48
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITOL
Route : IV(INFUSION)
CAS : 50-70-4
UNII : 506T60A25R
Potency Amount : 4.7
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES